Intrinsic Value of S&P & Nasdaq Contact Us

Senseonics Holdings, Inc. SENS NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+33.3%

Senseonics Holdings, Inc. (SENS) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 9 Buy, 4 Hold, 3 Sell.

The consensus price target is $9.00, representing an upside of 33.3% from the current price $6.75.

Analysts estimate Earnings Per Share (EPS) of $-2.53 and revenue of $0.02B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.50 vs est $-2.53 (beat +1.2%). 2025: actual $-1.66 vs est $-1.46 (missed -13.4%). Analyst accuracy: 93%.

SENS Stock — 12-Month Price Forecast

$9.00
▲ +33.33% Upside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Senseonics Holdings, Inc., the price target is $9.00.
The average price target represents a +33.33% change from the last price of $6.75.

SENS Analyst Ratings

Buy
16
Ratings
9 Buy
4 Hold
3 Sell
Based on 16 analysts giving stock ratings to Senseonics Holdings, Inc. in the past 3 months
Rating breakdown
Buy
9 56%
Hold
4 25%
Sell
3 19%
56%
Buy
9 analysts
25%
Hold
4 analysts
19%
Sell
3 analysts

EPS Estimates — SENS

93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$2.50 vs Est –$2.53 ▲ 1.2% off
2025 Actual –$1.66 vs Est –$1.46 ▼ 11.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — SENS

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.022B vs Est $0.022B ▲ 1.5% off
2025 Actual $0.035B vs Est $0.035B ▲ 0.2% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message